NovoCure Ltd (MEX:NVCR)
MXN 275.39 0 (0%) Market Cap: 37.69 Bil Enterprise Value: 32.64 Bil PE Ratio: 0 PB Ratio: 5.71 GF Score: 71/100

Q2 2023 Novocure Ltd Earnings Call Transcript

Jul 27, 2023 / 12:00PM GMT
Release Date Price: MXN694.37
Operator

Good day, and thank you for standing by. Welcome to the Novocure Q2 2023 Earnings Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Ingrid Goldberg. Please go ahead.

Ingrid Goldberg
NovoCure Limited - VP of IR

Good morning, everyone. Thank you for joining us to review Novocure's second quarter 2023 performance. I'm on the phone this morning with our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova. Other members of our executive leadership team are also on the call and available for Q&A. For your reference, slides accompanying this earnings release can be found on our website, www.novocure.com, on our Investor Relations page under quarterly reports.

Before we start, I would like to remind you that our discussions during this conference call will include forward-looking statements, and actual results could differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot